9 April 2024
9 April 2024 B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Investment Update – Pantheon Specialty Limited B.P. Marsh and…
8 April 2024
Caledonia Investments plc Transaction in own shares Caledonia Investments plc (“Caledonia”) announces that on 5 April 2024 it purchased from Winterflood Securities Limited 75,000…
Unaudited net asset value at 31 March 2024 and portfolio update Caledonia Investments plc (“Caledonia“), the self-managed FTSE 250 investment trust targeting long term…
08 April 2024 Enhertu approved in the US as first tumour-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumours Based on three…
4 April 2024
Chairman’s Statement Dear Shareholder The Merchants Trust was established in 1889, so in 2024 we mark the one hundred and thirty fifth anniversary. We…
2 April 2024
Caledonia Investments plc Transaction in own shares Caledonia Investments plc (“Caledonia”) announces that on 28 March 2024 it purchased from Winterflood Securities Limited 41,459…
As we announced at our Capital Markets Day in November 2023, from Q1 2024 we will be revising our reporting structure to align divisional…
2 April 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease…